Literature DB >> 8864788

Dobutamine stress echocardiography early after myocardial infarction treated with thrombolysis. Identification of myocardial viability and ischemia and relation to spontaneous functional recovery.

M Previtali1, L Lanzarini, A Poli, R Fetiveau, P Barberis.   

Abstract

The aim of the study was to assess the ability of dobutamine stress echocardiography to detect myocardial viability and ischemia in patients with acute myocardial infarction treated with thrombolysis and to correlate the acute response to dobutamine with late spontaneous functional recovery at follow-up. Forty-two consecutive patients with myocardial infarction treated with thrombolysis underwent low- (5 and 10 mcg/kg/min) and high-dose (20 to 40 mcg/kg/min) dobutamine stress echocardiography at a mean of 7 +/- 3 days of the acute phase. A follow-up 2D-echocardiogram was performed in all patients to evaluate the spontaneous recovery of function in the infarct area. On the basis of the response to the test, 3 groups of patients were identified: group 1 included 7 patients showing an improvement in left ventricular asynergy score index at low doses (from 1.5 +/- 0.3 to 1.3 +/- 0.2, p < 0.05) with no deterioration at high doses, indicative of myocardial viability without ischemia; group 2 (23 patients) showed a significant improvement in the asynergy index at low doses (from 1.58 +/- 0.3 to 1.32 +/- 0.32, p < 0.05) followed by a deterioration at high doses (1.68 +/- 0.4, p < 0.05 vs low-dose), suggestive of residual myocardial ischemia in the infarct zone; group 3 included 12 patients who showed no significant changes in the baseline asynergy score index (1.67 +/- 0.2) either at low or at high doses. The acute response to dobutamine stress echocardiography accurately predicted the spontaneous recovery of function in the infarct area at follow-up: both group 1 and group 2 patients showed a significant reduction in the asynergy score index (group 1: 1.16 +/- 0.3 vs 1.5 +/- 0.2, p < 0.001; group 2: 1.43 +/- 0.3 vs 1.58 +/- 0.3, p < 0.05), while group 3 had no recovery in the asynergy index (1.67 +/- 0.2 vs 1.67 +/- 0.2). Thus, in patients with acute myocardial infarction treated with thrombolysis dobutamine stress echocardiography can detect myocardial viability in 71% and ischemia in the infarct zone in 55% of patients; moreover, the response to the test during the acute phase is correlated with the degree of the late spontaneous recovery of function in the infarct area.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864788     DOI: 10.1007/bf01880740

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  19 in total

1.  Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial.

Authors:  P Marino; L Zanolla; P Zardini
Journal:  J Am Coll Cardiol       Date:  1989-11-01       Impact factor: 24.094

2.  Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.

Authors:  S L Meyer; G C Curry; M S Donsky; D B Twieg; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1976-07       Impact factor: 2.778

3.  Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography.

Authors:  L A Piérard; C M De Landsheere; C Berthe; P Rigo; H E Kulbertus
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

4.  Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method.

Authors:  G B Mancini; S B Simon; M J McGillem; M T LeFree; H Z Friedman; R A Vogel
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

5.  Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon?

Authors:  M Arnese; P M Fioretti; J H Cornel; J Postma-Tjoa; A E Reijs; J R Roelandt
Journal:  Am J Cardiol       Date:  1994-05-01       Impact factor: 2.778

6.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

7.  Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM study).

Authors:  R Schröder; K L Neuhaus; T Linderer; T Brüggemann; U Tebbe; K Wegscheider
Journal:  Am J Cardiol       Date:  1989-10-15       Impact factor: 2.778

8.  Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion.

Authors:  C Berthe; L A Pierard; M Hiernaux; G Trotteur; P Lempereur; J Carlier; H E Kulbertus
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

9.  Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation.

Authors:  S G Ellis; J Wynne; E Braunwald; C I Henschke; T Sandor; R A Kloner
Journal:  Am Heart J       Date:  1984-01       Impact factor: 4.749

Review 10.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.